Suchergebnisse - "Amiot, A"

PubPharm (10)

1

Comparative Risk of Incident Cancer in Patients with Inflammatory Bowel Disease with Prior Non-digestive Malignancy According to Immunomodulator : a Multicentre Cohort Study

enthalten in: Journal of Crohn's & colitis | 2022

von Poullenot, F. | Amiot, A. | Nachury, M. | +17

2

How to Manage Inflammatory Bowel Disease Patients When They Withdraw Anti-Tumour Necrosis Factor [Anti-TNF] Due to Severe Anti-TNF-Induced Skin Lesions? A Multicentre Cohort Study

enthalten in: Journal of Crohn's & colitis | 2022

von Cottron, C. | Treton, X. | Altwegg, R. | +13

3

Efficacy of a tailored PCR-guided triple therapy in the treatment of Helicobacter pylori infection

enthalten in: Medecine et maladies infectieuses | 2020

von Delchier, J. | Bastuji-Garin, S. | Raymond, J. | +27

4

Prognosis of Lymphoma in Patients With Known Inflammatory Bowel Disease : A French Multicentre Cohort Study

enthalten in: Journal of Crohn's & colitis | 2020

von Severyns, T. | Kirchgesner, J. | Lambert, J. | +15

5

Efficacy, Tolerability, and Safety of Low-Volume Bowel Preparations for Patients with Inflammatory Bowel Diseases : The French Multicentre CLEAN Study

enthalten in: Journal of Crohn's & colitis | 2019

von Briot, C. | Faure, P. | Parmentier, A. | +48

6

Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients : a multicentre experience

enthalten in: Alimentary pharmacology & therapeutics | 2018

von Wils, P. | Bouhnik, Y. | Michetti, P. | +19

7

Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease : a multicentre cohort study nested in the OBSERV-IBD cohort

enthalten in: Alimentary pharmacology & therapeutics | 2018

von Tadbiri, S. | Peyrin-Biroulet, L. | Serrero, M. | +95

8

Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab

enthalten in: Gut | 2018

von Laharie, D. | Bourreille, A. | Branche, J. | +28

9

One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease : a prospective multicentre cohort study

enthalten in: Alimentary pharmacology & therapeutics | 2017

von Amiot, A. | Serrero, M. | Peyrin-Biroulet, L. | +91

CommentIn: Aliment Pharmacol Ther. 2017 Sep;46(5):555-556. - PMID 28776739

10

Benefit of infliximab reintroduction after successive failure of infliximab and adalimumab in Crohn's disease

enthalten in: Journal of Crohn's & colitis | 2015

von Gagniere, C. | Beaugerie, L. | Pariente, B. | +6

1
[1]